TREATING HYPERCHOLESTEROLEMIA IN OLDER ADULTS FOR PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS: A JOINT STATEMENT BY THE AGS AND NATIONAL LIPID ASSOCIATION

Symposia

  • Date:
  • Time: 10:30am - 11:30am
  • Track: Clinical Practice
  • CME/CE: 1.0
  • Type: In-Person, Virtual

Moderator: Sunny Linnebur, PharmD, FCCP, BCPS, FASCP, BCGP
Presenters: Daniel E. Forman, MD & Ariel R. Greene, MD, MPH, PhD
This session will present key findings related to the assessment of Arteriosclerotic Cardiovascular Disease (ASCVD) risk in adults over age 75 years and the evidence for LDL-C lowering in this population.  Learning Objectives: (1) discuss limitations of evidence and recommendations related to older adults based on life expectancy, functional status, and cognitive status; (2) review evidence for adverse effects of statin therapies in this population; and (4) describe evidence for deprescribing.